Directory
>
Ran Zheng
Ran Zheng
Board Member | Caribou Biosciences
Boston, Massachusetts, United States
Ran Zheng
Summary
Ran Zheng is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as the CEO of Landmark Bio in Boston. With nearly three decades of experience, Ran has held various leadership roles, including Chief Technical Officer at Orchard Therapeutics and Vice President at Amgen. His expertise spans biopharmaceuticals, process engineering, and quality control, with a strong focus on advancing life sciences innovation. Ran's career began in Kendall Square, where he witnessed the rapid growth of the biotech industry. He is passionate about collaborating with academic institutions and research hospitals to drive therapeutic advancements. Ran's leadership at Landmark Bio emphasizes the integration of emerging technologies into clinical research. He holds a specialization in Microbial Engineering and Chemical Engineering from the University of Minnesota and has furthered his education at UCLA Anderson School of Management.
Ran Zheng
Work Experience
Board Member at
Caribou Biosciences
September 2021 - Present
Chief Executive Officer at
Landmark Associates, Biological Consulting, LLC
March 2021 - Present
Chief Technical Officer at
Orchard Therapeutics - U.S.
March 2019 - February 2021
Vice President, Development Supply Chain, Site Operations at
Amgen, Inc.
January 2016 - January 2019
Executive Director, Plant Manager at
Amgen, Inc.
January 2011 - January 2015
Executive Director, Plant Manager at
Amgen, Inc.
January 2006 - January 2010
Associate Director, Quality Control at
Amgen, Inc.
January 2005 - January 2006
Associate Director, Process Development at
Amgen, Inc.
January 2003 - January 2005
Associate Director, Process Engineering at
FUJIFILM Diosynth Biotechnologies
January 2000 - January 2003
Process Development Engineer, BioEngineering at
Sanofi
January 1996 - January 2000
Ran Zheng
Education
UCLA Anderson School of Management, Women’s Leadership Institute
Frequently Asked Questions about Ran Zheng
What is Ran Zheng email address?
Ran Zheng's primary email address is ******@landmarkbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ran Zheng work for?
Ran Zheng is a Board Member at Caribou Biosciences, a company specializing in Commercial physical research.
Where Ran Zheng graduated from?
Ran Zheng holds a degree in Microbial Engineering/Chemical Engineering from University of Minnesota Twin Cities.
How can I directly contact Ran Zheng?
To contact Ran Zheng directly, you can use the email address ******@landmarkbio.com. Complete contact information is available upon registration with Muraena.
Who is Ran Zheng?
Ran Zheng is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as the CEO of Landmark Bio in Boston. With nearly three decades of experience, Ran has held various leadership roles, including Chief Technical Officer at Orchard Therapeutics and Vice President at Amgen. His expertise spans biopharmaceuticals, process engineering, and quality control, with a strong focus on advancing life sciences innovation. Ran's career began in Kendall Square, where he witnessed the rapid growth of the biotech industry. He is passionate about collaborating with academic institutions and research hospitals to drive therapeutic advancements. Ran's leadership at Landmark Bio emphasizes the integration of emerging technologies into clinical research. He holds a specialization in Microbial Engineering and Chemical Engineering from the University of Minnesota and has furthered his education at UCLA Anderson School of Management.
Ran`s contact details
******@landmarkbio.com
*****@cariboubio.com
Colleagues
VP of Finance and Controller
Vice President Program Management - Therapeutics Product Development
Vice President of Operations and Information Technology
Chief People Officer
Executive Director, Stem Cell Therapeutics
Board Member
Board Member
VP of Platform Research
President and CEO
Vice President of Technical Operations